Grainne Quinn
Chief Tech/Sci/R&D Officer presso PERRIGO COMPANY PLC
Patrimonio netto: 678 501 $ in data 31/03/2024
Profilo
Attualmente Grainne Quinn ricopre la posizione di Chief Medical Officer & Executive Vice President presso Perrigo Co. Plc. La dottoressa Quinn ha precedentemente ricoperto la posizione di Chief Medical Officer per Elan Corp. Plc. La dottoressa Quinn ha ricevuto un dottorato dal Royal College of Surgeons.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PERRIGO CO. PLC
0.02% | 05/04/2024 | 21 078 ( 0.02% ) | 678 501 $ | 31/03/2024 |
Posizioni attive di Grainne Quinn
Società | Posizione | Inizio |
---|---|---|
PERRIGO COMPANY PLC | Chief Tech/Sci/R&D Officer | 01/11/2015 |
Precedenti posizioni note di Grainne Quinn
Società | Posizione | Fine |
---|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Chief Tech/Sci/R&D Officer | 01/12/2013 |
Formazione di Grainne Quinn
Royal College of Surgeons | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PERRIGO COMPANY PLC | Health Technology |
Aziende private | 1 |
---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Grainne Quinn